CCL5 and metabolic dysfunction-associated steatohepatitis: Other molecules inhibiting cell recruitment include propagermanium (CCR2 inhibitor) (181), mNOX-E36 (RNA-aptamer molecule that inhibits CCL2) (182), maraviroc (CCL5/RANTES inhibitor) (183) and small-molecule antagonist against the G protein-coupled receptor 84 (GPR84) (184) which ameliorate disease in experimental NASH.